Apigenin is a flavonoid (specifically 4′,5,7-trihydroxyflavone) found in chamomile flowers, parsley, celery, and thyme. It has attracted attention as a potential natural support for anxiety because it displaced a benzodiazepine-site ligand in rat brain binding assays, although in cells expressing human GABA-A receptors it inhibited GABA activation and did not act through that site; no human data compare its risk profile with prescription benzodiazepines [12][13][14]. For anyone interested in plant-based nervous-system support, understanding what the science actually says about apigenin is worth doing carefully.
The honest picture is mixed. Preclinical animal studies show real anxiolytic signals, and population data link higher flavonoid intake to lower anxiety rates. But isolated human clinical trials on apigenin for anxiety are thin, and most mechanistic data comes from cell cultures and rodent models. This article explains the proposed mechanisms, walks through the available evidence tier by tier, and covers the safety considerations that matter before anyone considers supplementing.
Key Takeaways
- Apigenin is reported to bind benzodiazepine sites on GABA-A receptors, though many flavonoid actions at these receptors do not depend on that site, so the basis for anxiolytic effects is plausible but uncertain [1].
- Animal studies show anxiolytic activity for apigenin and apigenin-containing plant extracts, but rodent data cannot directly confirm human efficacy [2].
- A placebo-controlled trial of chamomile extract in 57 outpatients with mild to moderate GAD lowered Hamilton Anxiety scores more than placebo (P = 0.047), though the effect cannot be isolated to apigenin, and a later relapse-prevention trial missed its primary endpoint [3][15][16][6].
- A cross-sectional US survey linked higher dietary apigenin intake to lower odds of anxiety, but the link weakened for most flavonoids after adjustment and cannot show cause [4].
- Apigenin inhibited CYP1A2, CYP2C9, and CYP3A4 in laboratory assays, and additive sedation with other CNS depressants is a theoretical concern; drug interaction review is sensible before supplementing [17][18][19][20].
What Apigenin Is and Where It Comes From
Apigenin belongs to the flavone subclass of polyphenols. Its chemical structure (three hydroxyl groups positioned at the 4′, 5, and 7 positions of the flavone backbone) allows it to interact with multiple biological targets, including enzymes and ion-channel receptors in the brain. It occurs naturally in chamomile (Matricaria recutita), parsley, celery, artichoke, and a range of herbs used historically for calming. Plants such as Perilla frutescens contain a broader array of flavonoids including apigenin, and ethnobotanical traditions have long used perilla-family plants for nervous-system complaints [5].
Within the body, apigenin is typically consumed as glycoside conjugates, bound to sugar molecules, that gut bacteria and intestinal enzymes cleave to release the free aglycone. Bioavailability varies considerably depending on the food matrix and individual gut microbiota composition. This variability is one reason dietary intake studies and supplement studies can produce different outcome signals. Researchers examining apigenin’s neuroactive properties have noted that its bioavailability and multi-target activity make it a meaningful candidate at the intersection of sleep, aging, and anxiety [6].
The GABA-A Receptor Mechanism
GABA (gamma-aminobutyric acid) is the central nervous system’s primary inhibitory neurotransmitter. The GABA-A receptor is an ion channel that, when activated, allows chloride ions to flow into neurons and reduce their excitability. Benzodiazepine drugs work by binding to a modulatory site on this receptor and enhancing GABA’s effect. Research into flavonoids as ligands for GABA-A receptors has found that flavonoids can enhance or reduce the effect of GABA at its receptors, with some likened to benzodiazepine-site ligands, though many of their actions are insensitive to the classic benzodiazepine antagonist flumazenil [1].
Research note: A WFSBP and CANMAT guideline taskforce did not recommend chamomile for generalised anxiety disorder, while lavender and ashwagandha were modestly supported [26].
Apigenin displaced a benzodiazepine-site ligand in rat brain binding assays with a Ki of 4 microM. In cells expressing human GABA-A receptors, however, it inhibited GABA activation on its own and did not act through the benzodiazepine site, so potentiation and any advantage on dependence are unproven [12][13][14]. Related flavonoids with similar hydroxylation patterns, including luteolin, have also been studied for neuropharmacological activity and show sedative and anxiolytic signals in preclinical models [7]. Broader reviews of neuroactive phytochemicals position apigenin within a class of multi-target plant compounds acting on inhibitory signaling, stress-response pathways, and neuroinflammation simultaneously [8].
Preclinical Evidence: What Animal Models Show
The most direct preclinical evidence for apigenin’s anxiolytic effects comes from rodent studies using validated behavioral tests such as the elevated plus maze. Apigenin 7-glucoside, a naturally occurring glycoside form of apigenin isolated from Stachys tibetica, demonstrated anxiolytic effects in rats; the effect appeared to involve the benzodiazepine receptor mechanism and was comparable to reference compounds [2].
Plant extracts containing apigenin as a major constituent have also shown relevant activity. An aqueous extract of Dracocephalum moldavica, with chemical analysis confirming its flavone content, produced sedative effects in mice in dose-dependent fashion [9]. It is important to note that such extracts contain multiple compounds, so observed effects cannot be attributed to apigenin alone. Similarly, research on Passiflora incarnata, which contains flavone constituents, has explored the GABAergic basis of its anxiolytic-like properties [10]. Flavone-related compounds like vitexin have been examined in neurological models as well, providing further indirect evidence that the flavone scaffold has meaningful CNS activity [11].
These animal findings are encouraging but carry standard caveats: rodent anxiety models do not map perfectly onto human anxiety disorders, oral bioavailability in rodents differs from humans, and doses used in some studies exceed realistic dietary or supplement intake. Preclinical data is best understood as hypothesis-generating rather than confirmatory.
Not every animal result agrees: in rats given apigenin by injection, apigenin reduced locomotor activity but showed no anxiolytic effect, while chrysin did [25].
Human Evidence: Clinical Trials and Population Data
The strongest human clinical evidence comes from a randomized, double-blind, placebo-controlled trial that used standardized chamomile extract, chamomile being the richest common dietary source of apigenin, in adults with generalized anxiety disorder (GAD). The trial, in 57 outpatients, found a significantly greater fall in Hamilton Anxiety scores than with placebo (P = 0.047) [3][6]. The limitation is important: chamomile extract is chemically complex, and the authors of a review say it is hard to tell whether apigenin or other components drive effects [6][23]. Attributing the full clinical effect to apigenin alone would be overreaching.
Chamomile extract helped modestly in one short anxiety trial, missed its relapse endpoint in another, and is not guideline-recommended
Anxiety scores fell more than placebo
In 57 outpatients with mild to moderate generalised anxiety disorder, chamomile extract lowered Hamilton Anxiety scores more than placebo (P = 0.047).
Primary outcome missed
After 12 weeks of open-label chamomile extract, 93 responders were randomised to chamomile or placebo. The lower relapse hazard was not significant (hazard ratio 0.52, 95% CI 0.20-1.33; P = 0.16).
Chamomile not recommended
A taskforce of 31 academics and clinicians from 15 countries graded herbal treatments and did not recommend chamomile for generalised anxiety disorder.
Chamomile extract has mixed, modest evidence for anxiety, and it is not apigenin.
Randomised placebo-controlled trials of chamomile extract plus a guideline taskforce grading. Source: Amsterdam et al., Journal of clinical psychopharmacology 2009; Mao et al., Phytomedicine 2016; Sarris et al., The world journal of biological psychiatry 2022
Embed this chart
Free to reuse on your site. Copy the code below; please keep the credit link.
At the population level, analysis of dietary intake data in 1,637 adults from the 2017-2018 National Health and Nutrition Examination Survey linked higher dietary apigenin intake to lower odds of anxiety, with anxiety classed from three self-reported questions and the association weakening for most flavonoids after adjustment [4]. Observational data cannot establish causation, people who consume more flavonoid-rich foods also tend to have healthier overall diets and lifestyles, but the finding is consistent with the mechanistic hypothesis and adds real-world plausibility. No isolated apigenin RCT for anxiety in humans has been published to date, which remains the most significant gap in the evidence base.
Dietary Sources vs. Isolated Supplements
The most accessible way to consume apigenin is through chamomile tea, which has been used for centuries as a calming beverage. Parsley, celery, thyme, oregano, and artichoke are also meaningful dietary sources. Regular consumption of these foods contributes to the broader flavonoid intake that population research has linked to lower anxiety scores [4]. For most people, a food-first approach is the most conservative starting point and aligns most closely with the dietary patterns studied in available research.
Isolated apigenin supplements are commercially available, typically in doses of 25 to 50 mg. These allow more precise dosing than dietary intake but deliver apigenin without the surrounding food matrix, which may affect absorption and which in whole foods provides additional bioactive compounds working together. Researchers examining apigenin’s sleep and anxiolytic properties note that its effects appear dose- and context-dependent, and that its properties across sleep and anxiety may be complementary rather than separate [6]. Whether isolated supplements produce meaningfully stronger anxiolytic effects than chamomile tea has not been established in controlled human trials.
Safety, Drug Interactions, and Who Should Be Cautious
In laboratory assays apigenin inhibited cytochrome P450 enzymes CYP1A2, CYP2C9, and CYP3A4, which metabolize a broad range of medications. No clinical interaction study exists. Warfarin is a commonly raised concern; the only chamomile case report involved a woman also taking amiodarone, so causation is not proven [17][18][19][21]. Certain statins, some antiepileptics, and other cardiovascular medications metabolized by CYP3A4 are also at risk of elevated concentrations. Anyone taking prescription medications should consult a physician before adding apigenin supplements to their routine.
Because apigenin acts on GABA-A receptors, additive sedation with other CNS depressants is a theoretical risk [20][22]. This includes benzodiazepines, alcohol, and over-the-counter sleep aids containing melatonin. The combination may amplify sedation beyond what either agent would produce alone. Pregnant and breastfeeding individuals should avoid supplements, as safety data for these populations is not available. At dietary intake levels from food, apigenin is generally regarded as safe for healthy adults, but supplemental doses warrant careful consideration of co-administered substances and medications.
đź›’ Where to Buy Apigenin
- Momentous Apigenin
capsules, 50 mg per capsule, 60 count: NSF Certified for Sport, meaning batch testing against a banned-substance list and verification that the label matches the contents - Vitamatic Apigenin 50mg
capsules, 50 mg per capsule, 120 vegetarian capsules: The lowest cost per dose on this list, and a vegetarian capsule if gelatin is a constraint; the listing states no third-party certification - Nutricost Apigenin 50mg
capsules, 50 mg per capsule, 180 count: Non-GMO, gluten free and vegan, and the best cost per capsule among the larger bottles here - Swanson Apigenin 50mg
capsules, 50 mg per capsule, 90 count: A long-established supplement brand, in the smaller 90-count bottle; the listing frames it around sleep and relaxation
As an Amazon Associate we earn from qualifying purchases. Apigenin products differ mainly in what else is in the capsule (some are plain apigenin, others blend it with L-theanine, valerian root or magnesium) so check the label for the actual apigenin dose per serving, and prefer products that publish third-party testing.
A Note on the Evidence
Most apigenin anxiety research involves animal models or complex whole-plant extracts rather than isolated apigenin in human clinical trials, so the evidence base remains preliminary and these statements have not been evaluated by the FDA: apigenin is not intended to diagnose, treat, cure, or prevent any disease. Individuals taking warfarin, benzodiazepines, statins, or other medications metabolized by CYP1A2, CYP2C9, or CYP3A4 should consult a physician before use, and extra caution is warranted when combining apigenin with any sedative agent including alcohol and melatonin.
Frequently Asked Questions
How does apigenin reduce anxiety at the molecular level?
Apigenin displaced a benzodiazepine-site ligand in rat brain binding assays, but in cells expressing human GABA-A receptors it inhibited the effect of GABA, the brain’s primary inhibitory neurotransmitter, and did not act through the benzodiazepine site [12][13][14][1]. Whether this produces a calming effect in people is not established, and no human trial of isolated apigenin for anxiety exists [13][24].
Is there human clinical evidence that apigenin reduces anxiety?
No isolated apigenin human trial for anxiety has been published. The best available human evidence is a randomized controlled trial showing that standardized chamomile extract (in which it is not known whether apigenin or other components drive effects) lowered Hamilton Anxiety scores more than placebo (P = 0.047) in 57 outpatients with generalized anxiety disorder [3][6]. Population survey data also associate higher flavonoid intake with lower anxiety [4], but neither finding proves that apigenin alone is responsible for the observed effects.
Can I get enough apigenin from chamomile tea?
Chamomile tea is among the richest practical dietary sources of apigenin. The chamomile anxiety trial used a standardized extract delivering a defined apigenin-equivalent dose [3], which may differ from brewed tea depending on steeping time, water temperature, and the specific product. Tea is the most accessible route, though supplement forms allow more precise and consistent dosing; chamomile tea was null in a study of 55 cancer patients, so tea is not a validated anxiety treatment [22].
Does apigenin interact with medications?
Possibly, but only laboratory data exist. Apigenin inhibited CYP1A2, CYP2C9, and CYP3A4 in enzyme assays, and these enzymes metabolize many common prescription drugs. Warfarin is the usual concern, but no clinical study of apigenin and warfarin exists [17][18][19][21]. Certain statins and benzodiazepines are also metabolized by these pathways. Anyone on prescription medications should consult their physician before using apigenin supplements; this is not optional caution.
Is it safe to combine apigenin with melatonin or alcohol?
Combining apigenin with other sedative agents, including melatonin, alcohol, or sleep medications, could in theory add to CNS depression, since apigenin interacts with GABA-A receptors in laboratory studies [20][13][6]. The cumulative sedative effect of multiple agents acting on overlapping systems can exceed what any single agent would produce. Stacking sedatives without medical supervision is not recommended.
How do related flavonoids like luteolin and vitexin compare to apigenin for anxiety?
Luteolin, which differs from apigenin by a single additional hydroxyl group, has been studied for neuropharmacological activity and shows sedative and anxiolytic-like properties in preclinical models [7]. Vitexin, another flavone found in some of the same plants, has been examined in neurological models involving kindling protocols [11]. These findings suggest the broader flavone class has CNS-relevant activity, though each compound carries its own receptor binding profile, bioavailability, and pharmacokinetics that differ meaningfully.
References
- Johnston GA et al. Flavonoid nutraceuticals and ionotropic receptors for the inhibitory neurotransmitter GABA. Neurochemistry international (2015). PMID 26190180
- Kumar D et al. Apigenin 7-glucoside from Stachys tibetica Vatke and its anxiolytic effect in rats. Phytomedicine : international journal of phytotherapy and phytopharmacology (2014). PMID 24462214
- Amsterdam JD et al. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of clinical psychopharmacology (2009). PMID 19593179
- Jin L et al. Association between dietary flavonoid intake and anxiety: data from NHANES 2017-2018. BMC public health (2025). PMID 40264109
- Ahmed HM et al. Ethnomedicinal, Phytochemical and Pharmacological Investigations of Perilla frutescens (L.) Britt. Molecules (Basel, Switzerland) (2018). PMID 30597896
- Kramer DJ et al. Apigenin: a natural molecule at the intersection of sleep and aging. Frontiers in nutrition (2024). PMID 38476603
- Coleta M et al. Assessment of luteolin (3',4',5,7-tetrahydroxyflavone) neuropharmacological activity. Behavioural brain research (2008). PMID 18249450
- Tkaczenko H et al. Neuroactive Phytochemicals as Multi-Target Modulators of Mental Health and Cognitive Function: An Integrative Review. International journal of molecular sciences (2025). PMID 41009475
- MartĂnez-Vázquez M et al. Neuropharmacological study of Dracocephalum moldavica L. (Lamiaceae) in mice: sedative effect and chemical analysis of an aqueous extract. Journal of ethnopharmacology (2012). PMID 22469767
- Dhawan K et al. Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn.–a brief perspective. Addiction biology (2003). PMID 14690874
- De Oliveira DD et al. Long‑term effects of vitexin against development of pentylenetetrazole‑induced kindling in rats. Acta neurobiologiae experimentalis (2024). PMID 39392022
- Haydée Viola et al. Apigenin, a Component ofMatricaria recutitaFlowers, is a Central Benzodiazepine Receptors-Ligand with Anxiolytic Effects. Planta Medica (1995). PMID 7617761
- Campbell EL et al. The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A) receptors. Biochemical pharmacology (2004). PMID 15451406
- Goutman JD et al. Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors. European journal of pharmacology (2003). PMID 12586201
- Mao JJ et al. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Phytomedicine : international journal of phytotherapy and phytopharmacology (2016). PMID 27912875
- Atena Pasban et al. The Effect of Chamomile on Common Psychological Disorders Including Depression, Anxiety, Stress and Sleep Disorders: A Narrative Review. Iranian Journal of Psychiatry and Behavioral Sciences (2025). doi:10.5812/ijpbs-157547
- Wang Z et al. Inhibitory Effect of Apigenin on Losartan Metabolism and CYP2C9 Activity in vitro. Pharmacology (2016). PMID 27287328
- Shimada H et al. Differential mechanisms for the inhibition of human cytochrome P450 1A2 by apigenin and genistein. Journal of biochemical and molecular toxicology (2010). PMID 20806393
- KondĹľa M et al. Characterization of the CYP3A4 Enzyme Inhibition Potential of Selected Flavonoids. Molecules (Basel, Switzerland) (2021). PMID 34069400
- National Center for Complementary and Integrative Health (NIH) Chamomile: Usefulness and Safety. National Center for Complementary and Integrative Health (NIH) source
- R. Segal Warfarin interaction with Matricaria chamomilla. Canadian Medical Association Journal (2006). PMID 16636327
- Sogand Saadatmand et al. The Effect of Oral Chamomile on Anxiety: A Systematic Review of Clinical Trials. Clinical Nutrition Research (2024). PMID 38784853
- Jay D. Amsterdam et al. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study. PubMed (2012). PMID 22894890
- Yajie Xu et al. Protective Roles of Apigenin Against Cardiometabolic Diseases: A Systematic Review. Frontiers in Nutrition (2022). PMID 35495935
- Zanoli P et al. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia (2000). PMID 10930722
- Sarris J et al. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry (2022). PMID 35311615
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
